Study on the serology identification of para-Bombay phenotype and the investigation of a family

doi:10.3969/j.issn.1673-8640.2015.09.002

Abstract

Abstract: Objective

To study the correct serology identification methods of para-Bombay phenotype and search compatible donors for rare blood type.

Methods

A total of 4 cases of positive and reverse typing discrepancy were identified comprehensively. ABO positive and reverse typing, Lewis blood type identification, H antigen detection, red blood cell absorption-elution test, cold antibody detection and hemagglutination inhibition test for blood type substance in saliva were performed. A family investigation was made.

Results

All the 4 cases were confirmed as para-Bombay phenotype. Proband c's sister was also proved that she was the same para-Bombay phenotype.

Conclusions

The cases of positive and reverse typing discrepancy should be added other essential tests for para-Bombay phenotype. The detection of cold antibody assists in not only identifying para-Bombay phenotype but also selecting compatible blood for transfusion. Family investigation makes possible observe source and inheritance of para-Bombay phenotype and provide homogeneous donors for transfusion.

Key words: Para-Bombay phenotype, ABD positive and reverse typing, H antigen, Cold antibody

CLC Number:

R446.11

ZHU Zehang, LU Yuanshan. Study on the serology identification of para-Bombay phenotype and the investigation of a family[J]. Laboratory Medicine, 2015, 30(9): 874-876.

Figures/Tables 3

References 11

[1]	SCHENKEL-BRUNNER H.ABO system. Human blood groups chemical and biochemical basis of antigen specificity[M]. 2nd edition. New York:Springer wien, 2000:110-117.
[2]	樊凤艳,王洪波,魏少平,等. 不规则抗体导致ABO正反定型不符处理探讨[J]. 检验医学,2012,27(10):822-824.
[3]	江慧. 常规血型鉴定发现类孟买型Bhm1例[J]. 检验医学与临床, 2013,10(18):2494.
[4]	郭忠慧, 向东, 朱自严, 等. 中国类孟买血型FUT1和FUT2基因研究[J]. 中华医学遗传学杂志,2004,21(5): 417-421.
[5]	向东, 张雄民, 朱自严, 等. 1例类孟买血型的鉴定及输血[J]. 中国输血杂志,2004,17(4):275-276.
[6]	BLUMENFELD OO, PATNAIK SK.Allelic genes of blood group antigens:a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database[J]. Hum Mutat, 2004 , 23(1):8-16.
[7]	杰夫·丹尼尔. 人类血型[M]. 朱自严,译. 2版. 北京:科学出版社, 2007:8-79.
[8]	许国先, 洪小珍, 刘瑛, 等. 一个类孟买血型家系的α1,2岩藻糖基转移酶基因突变分析[J]. 中华医学遗传学杂志, 2010, 27(3):250-254.
[9]	林甲进, 黄颖, 朱碎永. 一例类孟买血型的家系分析和分子机制研究[J]. 中华医学遗传学杂志, 2013, 30(2): 165-167.
[10]	吴远军, 刘景春, 刘兴玲, 等. 类孟买血型OHmB的血型血清学及家系调查[J]. 第四军医大学学报, 2006, 27(19):1778-1781.
[11]	骆宏, 林健伟, 张润青, 等. 类孟买血型两例的分子遗传机制研究[J]. 中华检验医学杂志, 2012, 35(9):815-819.

被检者	RBC与抗体试剂反应					血清与试剂红细胞反应
被检者	抗-A	抗-B	抗-H	抗Le^a	抗Le^b	Ac	Bc	Oc	自身c
a	-	-	-	-	1+^w	2+^s	-	±	-
b	-	-	-	-	1+	3+	±	±	-
c	-	-	-	-	1+	4+	1+	2+	-
d	-	-	-	-	1+	1+^w	1+^w	1+^w	-

被检者	RBC与抗体试剂反应					血清与试剂红细胞反应
被检者	抗-A	抗-B	抗-H	抗Le^a	抗Le^b	Ac	Bc	Oc	自身c
a	-	-	-	-	1+^w	2+^s	-	±	-
b	-	-	-	-	1+	3+	±	±	-
c	-	-	-	-	1+	4+	1+	2+	-
d	-	-	-	-	1+	1+^w	1+^w	1+^w	-

被检者	(红细胞+人源抗-A)放散液+Ac	(红细胞+人源抗-B)放散液+Bc	Oc放散液(对照)
a	-	2+	-
b	-	1+	-
c	-	2+	-
d	2+	1+^s	-

被检者	(红细胞+人源抗-A)放散液+Ac	(红细胞+人源抗-B)放散液+Bc	Oc放散液(对照)
a	-	2+	-
b	-	1+	-
c	-	2+	-
d	2+	1+^s	-

[1]	LI Li, SHI Huaying, Zaxiyangzong , Dawazhuoma , CHEN Yanmei, YANG Chunjiao, WEN Honglin. Application of indirect method in establishing reference range of adult blood lipids in Lhasa [J]. Laboratory Medicine, 2025, 40(11): 1064-1069.
[2]	SHEN Zhiying, CHEN Ming, DONG Yueying. Correlation between serum Hcy，S100B levels and cerebral metabolite indicators and cognitive impairment in elderly AIS patients [J]. Laboratory Medicine, 2025, 40(11): 1097-1101.
[3]	CHEN Wenli, JIN Cheng, ZHOU Lulu, XU Weiyi. Role of MicroR in guiding platelet count re-examination [J]. Laboratory Medicine, 2025, 40(9): 897-900.
[4]	WANG Qiuju, XIAO Huijian, WU Shuang, ZHAO Wanting, DAI Xubo, ZHUANG Yuepeng. Role of peripheral blood lymphocyte morphological classification in curative effect judgment of critical influenza [J]. Laboratory Medicine, 2025, 40(9): 901-906.
[5]	ZHANG Hui, YUAN Jingwen, ZHANG Chi. Adult reference ranges for platelet count and platelet-related parameters using fluorescence method in Wuhan [J]. Laboratory Medicine, 2025, 40(9): 892-896.
[6]	SHI Shaoxin, CHEN Xueting, XU Xiaofeng, LU Renquan, GUO Lin, ZHUANG Yihui. Role of coagulation function in bacterial bloodstream infection among malignant tumor patients [J]. Laboratory Medicine, 2025, 40(8): 804-809.
[7]	JIANG Fengying, JIANG Yun, MI Rui, QIAN Ximing, WANG Qiubo. Changes of platelet and coagulation function indicators in elderly patients with diabetic foot ulcers [J]. Laboratory Medicine, 2025, 40(7): 708-712.
[8]	YAO Lifeng, ZHANG Ling. Research progress on clinical significance of monocyte distribution width in infection and inflammatory diseases [J]. Laboratory Medicine, 2025, 40(5): 503-507.
[9]	DAI Jingwen, YANG Shuo, WANG Chong, SUN Lin, GU Meixiu, XIAN Jingrong, PAN Baishen, WANG Beili, ZHANG Chunyan, GUO Wei. Role of preoperative mean corpuscular hemoglobin concentration for predicting postoperative recurrence in intrahepatic cholangiocarcinoma patients [J]. Laboratory Medicine, 2025, 40(4): 344-349.
[10]	ZHANG Haoyang, LU Lin, ZONG Ming, HE Long, DING Yuanyuan, FAN Lieying. Diagnostic and predictive value of white blood cell population data in patients with sepsis [J]. Laboratory Medicine, 2025, 40(3): 271-277.
[11]	ZHOU Jiakuan, GUO Ping, CAI Qi, YANG Mingkang, HUANG Zhixi, XUE Yilun, HUA Renxiang, LIN Han, LI Jiaming, WANG Jianbiao. Molecular epidemiological analysis of patients with increased stomatocytes and giant platelets in peripheral blood [J]. Laboratory Medicine, 2025, 40(2): 171-177.
[12]	WANG Chengyun, GU Ping, PAN Qiuhui, WANG Jing. Changes and clinical value of blood coagulation indexes in children with infection [J]. Laboratory Medicine, 2025, 40(2): 178-181.
[13]	. [J]. Laboratory Medicine, 2025, 40(2): 197-200.
[14]	ZHANG Lan, ZHU Jianfeng, PAN Baishen, CHEN Pu, WANG Beili, GUO Wei. Prognostic value of circulating plasma cells determined by morphology in newly diagnosed multiple myeloma [J]. Laboratory Medicine, 2025, 40(1): 15-19.
[15]	CUI Weiqi, OU Xinyang, ZHAO Chunhe, XIA Wei, QU Linlin. Progress of thrombin-activatable fibrinolysis inhibitor determination in clinical application [J]. Laboratory Medicine, 2024, 39(10): 1021-1026.